Modification of a promiscuous inhibitor shifts the inhibition from γ-secretase to FLT-3
摘要:
The inhibition of FLT-3 activity is an interesting target for the treatment of acute myeloid leukemia (AML). The serendipitous identification of FLT-3 inhibitors from a CK1/gamma-secretase programme provided compounds with dual inhibitory activity. We analyzed the structure-activity relationship of these inhibitors and derivatized them to arrive at compounds with reduced impact on gamma-secretase activity and enhanced FLT-3 inhibition. (C) 2012 Elsevier Ltd. All rights reserved.
Modification of a promiscuous inhibitor shifts the inhibition from γ-secretase to FLT-3
摘要:
The inhibition of FLT-3 activity is an interesting target for the treatment of acute myeloid leukemia (AML). The serendipitous identification of FLT-3 inhibitors from a CK1/gamma-secretase programme provided compounds with dual inhibitory activity. We analyzed the structure-activity relationship of these inhibitors and derivatized them to arrive at compounds with reduced impact on gamma-secretase activity and enhanced FLT-3 inhibition. (C) 2012 Elsevier Ltd. All rights reserved.
Development of Receptor for Advanced Glycation End Products (RAGE) ligands through target directed dynamic combinatorial chemistry: a novel class of possible antagonists
Tackling the Receptor for Advanced Glycation End Products (RAGE) inhibition via Dynamic CombinatorialChemistry (DCC). Leveraging protein recognition, in the presence of a continually self-correcting, evolving dynamic library, we were able to find novel ligands for RAGE. Our biological tests confirmed their superior affinities, as well as potential as antagonists, a fresh perspective for inhibiting